publication . Article . 2015

Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?

Carlotta Lassandro; Giuseppe Banderali; Giovanni Radaelli; Elisa Borghi; Francesca Moretti; Elvira Verduci;
Open Access English
  • Published: 01 Aug 2015 Journal: International Journal of Molecular Sciences, volume 16, issue 8, pages 19,989-20,000 (issn: 1422-0067, eissn: 1422-0067, Copyright policy)
  • Publisher: MDPI
Abstract
Prevalence of metabolic syndrome is increasing in the pediatric population. Considering the different existing criteria to define metabolic syndrome, the use of the International Diabetes Federation (IDF) criteria has been suggested in children. Docosahexaenoic acid (DHA) has been associated with beneficial effects on health. The evidence about the relationship of DHA status in blood and components of the metabolic syndrome is unclear. This review discusses the possible association between DHA content in plasma and erythrocytes and components of the metabolic syndrome included in the IDF criteria (obesity, alteration of glucose metabolism, blood lipid profile, a...
Subjects
free text keywords: Chemistry, blood pressure, QD1-999, Blood pressure; DHA; Glucose metabolism; Lipid profile; Metabolic syndrome; N-3 LCPUFA; NAFLD; Obesity, n-3 LCPUFA, QH301-705.5, metabolic syndrome, NAFLD, Review, lipid profile, DHA, glucose metabolism, obesity, Biology (General), Settore MED/38 - Pediatria Generale e Specialistica
63 references, page 1 of 5

Sabin, M.A., Kao, K.T., Juonala, M., Baur, L.A., Wake, M.. Viewpoint article: Childhood obesity-looking back over 50 years to begin to look forward. J. Paediatr. Child Health. 2015; 51: 82-86 [PubMed] [DOI]

Lakshman, R., Elks, C.E., Ong, K.K.. Childhood obesity. Circulation. 2012; 126: 1770-1779 [OpenAIRE] [PubMed] [DOI]

August, G.P., Caprio, S., Fennoy, I., Freemark, M., Kaufman, F.R., Lustig, R.H., Silverstein, J.H., Speiser, P.W., Styne, D.M., Montori, V.M.. Prevention and treatment of pediatric obesity: An endocrine society clinical practice guideline based on expert opinion. J. Clin. Endocrinol. Metab.. 2008; 93: 4576-4599 [OpenAIRE] [PubMed]

Pacifico, L., Giansanti, S., Gallozzi, A., Chiesa, C.. Long chain ω-3 polyunsaturated fatty acids in pediatric metabolic syndrome. Mini Rev. Med. Chem.. 2014; 14: 791-804 [PubMed] [DOI]

Weiss, R., Bremer, A.A., Lustig, R.H.. What is metabolic syndrome, and why are children getting it?. Ann. N. Y. Acad. Sci.. 2013; 1281: 123-140 [OpenAIRE] [PubMed] [DOI]

Owens, S., Galloway, R.. Childhood obesity and the metabolic syndrome. Curr. Atheroscler. Rep.. 2014; 16: 436:1-436:8 [PubMed] [DOI]

Friend, A., Craig, L., Turner, S.. The prevalence of metabolic syndrome in children: A systematic review of the literature. Metab. Syndr. Relat. Disord.. 2013; 11: 71-80 [PubMed] [DOI]

Zimmet, P., Alberti, K.G., Kaufman, F., Tajima, N., Silink, M., Arslanian, S., Wong, G., Bennett, P., Shaw, J., Caprio, S.. The metabolic syndrome in children and adolescents—An IDF consensus report. Pediatr. Diabetes. 2007; 8: 299-306 [PubMed] [DOI]

Laurson, K.R., Welk, G.J., Eisenmann, J.C.. Diagnostic performance of BMI percentiles to identify adolescents with metabolic syndrome. Pediatrics. 2014; 133: e330-e338 [PubMed] [DOI]

Asrih, M., Jornayvaz, F.R.. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?. Mol. Cell. Endocrinol.. 2015 [OpenAIRE] [PubMed] [DOI]

Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., Loria, P.. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Dig. Liver Dis.. 2015; 47: 181-190 [OpenAIRE] [PubMed] [DOI]

Patton, H.M., Yates, K., Unalp-Arida, A., Behling, C.A., Huang, T.T., Rosenthal, P., Sanyal, A.J., Schwimmer, J.B., Lavine, J.E.. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am. J. Gastroenterol.. 2010; 105: 2093-2102 [OpenAIRE] [PubMed] [DOI]

Alterio, A., Alisi, A., Liccardo, D., Nobili, V.. Non-alcoholic fatty liver and metabolic syndrome in children: A vicious circle. Horm. Res. Paediatr.. 2014; 82: 283-289 [PubMed] [DOI]

Tarantino, G., Finelli, C.. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?. World J. Gastroenterol.. 2013; 19: 3375-3384 [OpenAIRE] [PubMed] [DOI]

Russell, F.D., Bürgin-Maunder, C.S.. Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids. Mar. Drugs. 2012; 10: 2535-2559 [OpenAIRE] [PubMed] [DOI]

63 references, page 1 of 5
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2015

Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?

Carlotta Lassandro; Giuseppe Banderali; Giovanni Radaelli; Elisa Borghi; Francesca Moretti; Elvira Verduci;